1. "Steven Horwitz"
Formats
  1. Meeting Abstract (328)
  2. Journal Article (222)
  3. Guidelines (9)
  4. Review (9)
  5. Book Section (6)
  6. Correspondence (3)
  7. Research Letter (3)
  8. Editorial (2)
Groups
  1. Center for Hematologic Malignancies (582)
  2. Department of Medicine (582)
  3. Hematologic Malignancies, Division of (582)
  4. Lymphoma (582)
  5. Population Sciences Research Program (582)
  6. Survivorship Research (150)

More Groups

People
  1. Steven Horwitz (582)
  2. Alison Moskowitz (188)
  3. Andrew Zelenetz (143)
  4. David Straus (116)
  5. Paul Hamlin (113)
  6. Ariela Noy (111)

More People

Years
  1. 2023 (21)
  2. 2022 (34)
  3. 2021 (53)
  4. 2020 (52)
  5. 2019 (64)
  6. 2018 (38)

More Years

Publications
  1. Blood (211)
  2. Journal of Clinical Oncology (61)
  3. Hematological Oncology (38)
  4. Annals of Oncology (18)
  5. Clinical Lymphoma, Myeloma and Leukemia (17)
  6. Leukemia and Lymphoma (17)

More Publications

Publishers
  1. American Society of Hematology (227)
  2. American Society of Clinical Oncology (62)
  3. Wiley Blackwell (53)
  4. Elsevier Inc. (31)
  5. Oxford University Press (25)
  6. Taylor & Francis Group (21)

More Publishers

Results (582)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • TP63 fusions drive multicomplex enhancer rewiring, lymphomagenesis, and EZH2 dependence
    Journal Article

    Wu, G.; Yoshida, N.; Liu, J.; Zhang, X.; Xiong, Y.; Heavican-Foral, T. B.; Mandato, E.; Liu, H.; Nelson, G. M.; Yang, L.; more...
    Science Translational Medicine (2023)

    Fulltext@MSK | Save
  • The SALENTO prognostic model for limited-stage peripheral T-cell lymphoma from the International T-Cell Project Network
    Journal Article

    Hapgood, G.; Civallero, M.; Stepanishyna, Y.; Vose, J.; Cabrera, M. E.; Advani, R. H.; Pileri, S. A.; Manni, M.; Horwitz, S. M.; Foss, F. M.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • TP53 mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapy
    Journal Article

    Johnson, W. T.; Ganesan, N.; Epstein-Peterson, Z. D.; Moskowitz, A. J.; Stuver, R. N.; Maccaro, C. R.; Galasso, N.; Chang, T.; Khan, N.; Aypar, U.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Retrospective characterization of nodal marginal zone lymphoma
    Journal Article

    Stuver, R.; Drill, E.; Qualls, D.; Okwali, M.; Batlevi, C. L.; Caron, P. C.; Dogan, A.; Epstein-Peterson, Z. D.; Falchi, L.; Hamlin, P. A.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • A multi-institutional prospective cohort study of minimal residual disease in peripheral T-cell lymphoma: Impact of autologous stem cell transplant
    Meeting Abstract

    Foley, N. C.; Russler-Germain, D.; Watkins, M.; Jacobsen, E. D.; Moskowitz, A. J.; Cashen, A. F.; Fehniger, T. A.; Kahl, B. S.; Ghobadi, A.; Reagan, B.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Giant cell myocarditis after mogamulizumab
    Meeting Abstract

    Marshall, D. P.; Sobol, I.; Horwitz, S.; Krishnan, U.; Abrams, J.; Zhang, C.; Mahmood, S. S.
    Journal of the American College of Cardiology (2023)

    Fulltext@MSK | Save
  • Treatment of adult T-cell leukemia/lymphoma: Established paradigms and emerging directions
    Review

    Stuver, R.; Horwitz, S. M.; Epstein-Peterson, Z. D.
    Current Treatment Options in Oncology (2023)

    Fulltext@MSK | Save
  • Final results of a phase II study of CHOEP plus lenalidomide as initial therapy for patients with stage II–IV peripheral T-cell lymphoma
    Journal Article

    Stuver, R.; Horwitz, S. M.; Advani, R. H.; Vose, J. M.; Lee, H. J.; Mehta-Shah, N.; Zain, J. M.; Haverkos, B.; Lechowicz, M. J.; Moskowitz, A. J.; more...
    British Journal of Haematology (2023)

    Fulltext@MSK | Save
  • Long term outcome of peripheral T cell lymphomas: 10y follow‐up analysis of the International Prospective T Cell Project Network
    Meeting Abstract

    Civallero, M.; Advani, R.; Horwitz, S.; Manni, M.; Cabrera, M. E.; Vose, J.; Spina, M.; Hits, F.; Nagler, A.; Montoto, S.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Duvelisib in patients with relapsed/refractory peripheral T‐cell lymphoma from the phase 2 PRIMO Trial Expansion Phase: Outcomes by baseline histology
    Meeting Abstract

    Mehta‐Shah, N.; Jacobsen, E. D.; Zinzani, P. L.; Zain, J.; Mead, M.; Casulo, C.; Gritti, G.; Pinter‐Brown, L.; Izutsu, K.; Waters, S.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save